Annual CFF
$58.12 M
+$46.24 M+389.21%
December 31, 2023
Summary
- As of February 12, 2025, KYTX annual cash flow from financing activities is $58.12 million, with the most recent change of +$46.24 million (+389.21%) on December 31, 2023.
- During the last 3 years, KYTX annual CFF has fallen by -$14.40 million (-19.86%).
- KYTX annual CFF is now -19.86% below its all-time high of $72.52 million, reached on December 1, 2021.
Performance
KYTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$152.00 K
+$417.00 K+73.29%
September 30, 2024
Summary
- As of February 12, 2025, KYTX quarterly cash flow from financing activities is -$152.00 thousand, with the most recent change of +$417.00 thousand (+73.29%) on September 30, 2024.
- Over the past year, KYTX quarterly CFF has increased by +$1.28 million (+89.40%).
- KYTX quarterly CFF is now -100.04% below its all-time high of $338.05 million, reached on March 31, 2024.
Performance
KYTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$335.89 M
-$34.94 M-9.42%
September 30, 2024
Summary
- As of February 12, 2025, KYTX TTM cash flow from financing activities is $335.89 million, with the most recent change of -$34.94 million (-9.42%) on September 30, 2024.
- Over the past year, KYTX TTM CFF has increased by +$277.78 million (+477.95%).
- KYTX TTM CFF is now -15.24% below its all-time high of $396.31 million, reached on March 31, 2024.
Performance
KYTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KYTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +389.2% | +89.4% | +477.9% |
| 3 y3 years | -19.9% | +89.4% | +477.9% |
| 5 y5 years | -19.9% | +89.4% | +477.9% |
KYTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | +389.2% | -100.0% | +89.4% | -15.2% | >+9999.0% |
| 5 y | 5-year | -19.9% | +389.2% | -100.0% | +89.4% | -15.2% | >+9999.0% |
| alltime | all time | -19.9% | +389.2% | -100.0% | +89.4% | -15.2% | >+9999.0% |
Kyverna Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$152.00 K(-73.3%) | $335.89 M(-9.4%) |
| Jun 2024 | - | -$569.00 K(-100.2%) | $370.84 M(-6.4%) |
| Mar 2024 | - | $338.05 M(<-9900.0%) | $396.31 M(+581.9%) |
| Dec 2023 | $58.12 M | -$1.43 M(-104.1%) | $58.12 M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $34.79 M(+39.7%) | $59.55 M(+140.5%) |
| Jun 2023 | - | $24.91 M(<-9900.0%) | $24.76 M(<-9900.0%) |
| Mar 2023 | - | -$144.00 K | -$144.00 K |
| Dec 2022 | $11.88 M(-83.6%) | - | - |
| Dec 2021 | $72.52 M | - | - |
FAQ
- What is Kyverna Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual CFF year-on-year change?
- What is Kyverna Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly CFF year-on-year change?
- What is Kyverna Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kyverna Therapeutics?
- What is Kyverna Therapeutics TTM CFF year-on-year change?
What is Kyverna Therapeutics annual cash flow from financing activities?
The current annual CFF of KYTX is $58.12 M
What is the all time high annual CFF for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual cash flow from financing activities is $72.52 M
What is Kyverna Therapeutics annual CFF year-on-year change?
Over the past year, KYTX annual cash flow from financing activities has changed by +$46.24 M (+389.21%)
What is Kyverna Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of KYTX is -$152.00 K
What is the all time high quarterly CFF for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly cash flow from financing activities is $338.05 M
What is Kyverna Therapeutics quarterly CFF year-on-year change?
Over the past year, KYTX quarterly cash flow from financing activities has changed by +$1.28 M (+89.40%)
What is Kyverna Therapeutics TTM cash flow from financing activities?
The current TTM CFF of KYTX is $335.89 M
What is the all time high TTM CFF for Kyverna Therapeutics?
Kyverna Therapeutics all-time high TTM cash flow from financing activities is $396.31 M
What is Kyverna Therapeutics TTM CFF year-on-year change?
Over the past year, KYTX TTM cash flow from financing activities has changed by +$277.78 M (+477.95%)